ASMB: Assembly Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Assembly Biosciences Inc (ASMB).
$100.30M Market Cap.
ASMB Market Cap. (MRY)
ASMB Shares Outstanding (MRY)
ASMB Assets (MRY)
Total Assets
$119.17M
Total Liabilities
$85.81M
Total Investments
$73.73M
ASMB Income (MRY)
Revenue
$0
Net Income
-$40.18M
Operating Expense
$73.94M
ASMB Cash Flow (MRY)
CF Operations
-$51.12M
CF Investing
$40.17M
CF Financing
$29.45M
ASMB Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $119,168,000 (-12.90%) | $136,823,000 (34.41%) | $101,794,000 (-46.72%) | $191,060,000 (-32.55%) |
Assets Current | $115,503,000 (-13.67%) | $133,787,000 (37.97%) | $96,967,000 (-37.12%) | $154,204,000 (-31.31%) |
Assets Non-Current | $3,665,000 (20.72%) | $3,036,000 (-37.10%) | $4,827,000 (-86.90%) | $36,856,000 (-37.28%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $33,359,000 (-18.83%) | $41,097,000 (-50.28%) | $82,664,000 (-51.07%) | $168,929,000 (-29.78%) |
Property Plant & Equipment Net | $3,353,000 (23.09%) | $2,724,000 (-30.83%) | $3,938,000 (-45.16%) | $7,181,000 (-33.08%) |
Cash & Equivalents | $38,344,000 (93.26%) | $19,841,000 (-62.15%) | $52,418,000 (14.88%) | $45,627,000 (-23.24%) |
Accumulated Other Comprehensive Income | -$211,000 (-160.49%) | -$81,000 (89.91%) | -$803,000 (-91.65%) | -$419,000 (-55.19%) |
Deferred Revenue | $73,000,000 (-15.41%) | $86,294,000 (3057.48%) | $2,733,000 (0.00%) | $2,733,000 (-69.59%) |
Total Investments | $73,735,000 (-33.21%) | $110,406,000 (181.71%) | $39,192,000 (-69.61%) | $128,972,000 (-17.84%) |
Investments Current | $73,735,000 (-33.21%) | $110,406,000 (181.71%) | $39,192,000 (-61.20%) | $101,000,000 (-35.66%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $27,972,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $43,000 (-95.44%) | $944,000 (180.95%) | $336,000 (-72.68%) |
Trade & Non-Trade Payables | $585,000 (26.90%) | $461,000 (-81.51%) | $2,493,000 (-6.24%) | $2,659,000 (-42.17%) |
Accumulated Retained Earnings (Deficit) | -$825,925,000 (-5.11%) | -$785,748,000 (-8.45%) | -$724,520,000 (-14.74%) | -$631,428,000 (-25.89%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $3,089,000 (31.90%) | $2,342,000 (-32.41%) | $3,465,000 (-46.49%) | $6,476,000 (-36.06%) |
Debt Current | $461,000 (-62.21%) | $1,220,000 (-63.73%) | $3,364,000 (6.76%) | $3,151,000 (-7.43%) |
Debt Non-Current | $2,628,000 (134.22%) | $1,122,000 (1010.89%) | $101,000 (-96.96%) | $3,325,000 (-50.56%) |
Total Liabilities | $85,809,000 (-10.36%) | $95,726,000 (400.40%) | $19,130,000 (-13.56%) | $22,131,000 (-48.14%) |
Liabilities Current | $47,803,000 (21.87%) | $39,225,000 (140.70%) | $16,296,000 (1.39%) | $16,073,000 (-34.22%) |
Liabilities Non-Current | $38,006,000 (-32.73%) | $56,501,000 (1893.68%) | $2,834,000 (-53.22%) | $6,058,000 (-66.79%) |
ASMB Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $6,254,000 (-92.09%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $18,007,000 (-21.40%) | $22,909,000 (-5.08%) | $24,134,000 (-16.14%) | $28,780,000 (-22.34%) |
Research & Development Expense | $55,933,000 (14.38%) | $48,900,000 (-30.12%) | $69,980,000 (2.12%) | $68,524,000 (-35.85%) |
Operating Expenses | $73,940,000 (2.97%) | $71,809,000 (-23.70%) | $94,114,000 (-32.26%) | $138,942,000 (-3.43%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $330,000 (900.00%) | $33,000 (0%) | $0 (0%) | -$2,531,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$40,177,000 (34.38%) | -$61,228,000 (34.23%) | -$93,092,000 (28.31%) | -$129,855,000 (-108.93%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$40,177,000 (34.38%) | -$61,228,000 (34.23%) | -$93,092,000 (28.31%) | -$129,855,000 (-108.93%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$40,177,000 (34.38%) | -$61,228,000 (34.23%) | -$93,092,000 (28.31%) | -$129,855,000 (-108.93%) |
Weighted Average Shares | $6,004,560 (31.18%) | $4,577,371 (13.47%) | $4,034,105 (11.85%) | $3,606,699 (22.17%) |
Weighted Average Shares Diluted | $6,004,560 (31.18%) | $4,577,371 (13.47%) | $4,034,105 (11.85%) | $3,606,699 (22.17%) |
Earning Before Interest & Taxes (EBIT) | -$39,847,000 (34.89%) | -$61,195,000 (34.26%) | -$93,092,000 (29.68%) | -$132,386,000 (-113.00%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $6,254,000 (-92.09%) |
Operating Income | -$73,940,000 (-2.97%) | -$71,809,000 (23.70%) | -$94,114,000 (29.07%) | -$132,688,000 (-104.84%) |
ASMB Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $40,171,000 (158.10%) | -$69,138,000 (-176.28%) | $90,640,000 (241.84%) | $26,515,000 (-61.05%) |
Net Cash Flow from Financing | $29,449,000 (113.12%) | $13,818,000 (2150.49%) | $614,000 (-98.84%) | $53,064,000 (598.30%) |
Net Cash Flow from Operations | -$51,117,000 (-324.76%) | $22,743,000 (126.93%) | -$84,463,000 (9.56%) | -$93,396,000 (-48.35%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $18,503,000 (156.80%) | -$32,577,000 (-579.71%) | $6,791,000 (149.15%) | -$13,817,000 (-208.69%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $1,500,000 (0.00%) | $1,500,000 (185.71%) |
Net Cash Flow - Investment Acquisitions and Disposals | $40,199,000 (158.34%) | -$68,907,000 (-177.21%) | $89,242,000 (227.45%) | $27,254,000 (-61.23%) |
Capital Expenditure | -$28,000 (87.88%) | -$231,000 (-126.47%) | -$102,000 (95.44%) | -$2,239,000 (-376.38%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $29,449,000 (113.12%) | $13,818,000 (2150.49%) | $614,000 (-98.84%) | $53,064,000 (598.30%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $3,120,000 (-39.05%) | $5,119,000 (-22.36%) | $6,593,000 (25.89%) | $5,237,000 (-76.04%) |
Depreciation Amortization & Accretion | $129,000 (-71.33%) | $450,000 (-9.64%) | $498,000 (6.87%) | $466,000 (-32.56%) |
ASMB Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | 100.00% (0.00%) |
Profit Margin | - | - | - | -2076.40% (-2541.73%) |
EBITDA Margin | - | - | - | -2109.40% (-2614.80%) |
Return on Average Equity (ROAE) | -126.90% (-7.82%) | -117.70% (-44.06%) | -81.70% (-37.31%) | -59.50% (-146.89%) |
Return on Average Assets (ROAA) | -35.30% (51.24%) | -72.40% (-2.99%) | -70.30% (-32.89%) | -52.90% (-154.33%) |
Return on Sales (ROS) | - | - | - | -2116.80% (-2593.13%) |
Return on Invested Capital (ROIC) | -84.50% (41.64%) | -144.80% (-12.51%) | -128.70% (-39.29%) | -92.40% (-174.18%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -2.36 (-220.52%) | -0.74 (-8.88%) | -0.68 (13.00%) | -0.78 (77.52%) |
Price to Sales Ratio (P/S) | - | - | - | 16.13 (495.24%) |
Price to Book Ratio (P/B) | 3.01 (129.37%) | 1.31 (70.93%) | 0.77 (16.21%) | 0.66 (-20.48%) |
Debt to Equity Ratio (D/E) | 2.57 (10.43%) | 2.33 (908.23%) | 0.23 (76.34%) | 0.13 (-25.99%) |
Earnings Per Share (EPS) | -6.69 (50.00%) | -13.38 (42.03%) | -23.08 (35.89%) | -36 (-71.43%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 1.73 (-93.53%) |
Free Cash Flow Per Share (FCFPS) | -8.52 (-273.20%) | 4.92 (123.46%) | -20.96 (20.94%) | -26.52 (-23.42%) |
Book Value Per Share (BVPS) | 5.56 (-38.12%) | 8.98 (-56.19%) | 20.49 (-56.25%) | 46.84 (-42.52%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.85 (-33.61%) | 29.89 (18.46%) | 25.23 (-52.37%) | 52.97 (-35.27%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.84 (-298.49%) | -0.46 (-228.37%) | -0.14 (61.26%) | -0.36 (85.30%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0.03 (-90.53%) |
Current Ratio | 2.42 (-29.17%) | 3.41 (-42.67%) | 5.95 (-37.98%) | 9.59 (4.42%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$51,145,000 (-327.19%) | $22,512,000 (126.62%) | -$84,565,000 (11.58%) | -$95,635,000 (-50.78%) |
Enterprise Value (EV) | $73,292,193 (160.35%) | $28,151,043 (116.05%) | $13,029,981 (-72.85%) | $47,992,707 (-68.48%) |
Earnings Before Tax (EBT) | -$39,847,000 (34.89%) | -$61,195,000 (34.26%) | -$93,092,000 (29.68%) | -$132,386,000 (-113.00%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$39,718,000 (34.62%) | -$60,745,000 (34.40%) | -$92,594,000 (29.81%) | -$131,920,000 (-114.64%) |
Invested Capital | $36,110,000 (-54.92%) | $80,099,000 (119.18%) | $36,545,000 (-73.10%) | $135,836,000 (-19.08%) |
Working Capital | $67,700,000 (-28.41%) | $94,562,000 (17.22%) | $80,671,000 (-41.60%) | $138,131,000 (-30.96%) |
Tangible Asset Value | $119,168,000 (-12.90%) | $136,823,000 (34.41%) | $101,794,000 (-46.72%) | $191,060,000 (-20.92%) |
Market Capitalization | $100,302,193 (86.13%) | $53,888,043 (-15.02%) | $63,413,981 (-43.14%) | $111,517,707 (-44.18%) |
Average Equity | $31,661,250 (-39.14%) | $52,023,250 (-54.35%) | $113,959,750 (-47.76%) | $218,153,000 (-15.28%) |
Average Assets | $113,659,000 (34.45%) | $84,536,250 (-36.14%) | $132,371,750 (-46.03%) | $245,268,000 (-18.09%) |
Invested Capital Average | $47,157,750 (11.59%) | $42,259,500 (-41.56%) | $72,318,500 (-49.50%) | $143,211,000 (-22.43%) |
Shares | 6,356,286 (16.08%) | 5,475,759 (34.71%) | 4,064,999 (1.92%) | 3,988,473 (44.94%) |
